Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022
We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%). We observed no increase in the seroprevalence trend after widespread school reopening....
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2023-08-01
|
| Series: | Emerging Infectious Diseases |
| Online Access: | https://wwwnc.cdc.gov/eid/article/29/8/23-0471_article |
| _version_ | 1797775141024825344 |
|---|---|
| author | Rebecca A. Falender Paul G. Mitchell Judith A. Guzman-Cottrill Paul R. Cieslak Melissa Sutton |
| author_facet | Rebecca A. Falender Paul G. Mitchell Judith A. Guzman-Cottrill Paul R. Cieslak Melissa Sutton |
| author_sort | Rebecca A. Falender |
| collection | DOAJ |
| description |
We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%). We observed no increase in the seroprevalence trend after widespread school reopening. Seroprevalence estimates complement case-based cumulative incidence.
|
| first_indexed | 2024-03-12T22:31:27Z |
| format | Article |
| id | doaj.art-35f61817c7fa46b08fd223a5b97180c1 |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-03-12T22:31:27Z |
| publishDate | 2023-08-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-35f61817c7fa46b08fd223a5b97180c12023-07-21T14:59:09ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592023-08-012981672167510.3201/eid2908.230471Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022Rebecca A. FalenderPaul G. MitchellJudith A. Guzman-CottrillPaul R. CieslakMelissa Sutton We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%). We observed no increase in the seroprevalence trend after widespread school reopening. Seroprevalence estimates complement case-based cumulative incidence. https://wwwnc.cdc.gov/eid/article/29/8/23-0471_article |
| spellingShingle | Rebecca A. Falender Paul G. Mitchell Judith A. Guzman-Cottrill Paul R. Cieslak Melissa Sutton Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022 Emerging Infectious Diseases |
| title | Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022 |
| title_full | Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022 |
| title_fullStr | Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022 |
| title_full_unstemmed | Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022 |
| title_short | Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022 |
| title_sort | pediatric sars cov 2 seroprevalence oregon usa november 1 2020 june 30 2022 |
| url | https://wwwnc.cdc.gov/eid/article/29/8/23-0471_article |
| work_keys_str_mv | AT rebeccaafalender pediatricsarscov2seroprevalenceoregonusanovember12020june302022 AT paulgmitchell pediatricsarscov2seroprevalenceoregonusanovember12020june302022 AT judithaguzmancottrill pediatricsarscov2seroprevalenceoregonusanovember12020june302022 AT paulrcieslak pediatricsarscov2seroprevalenceoregonusanovember12020june302022 AT melissasutton pediatricsarscov2seroprevalenceoregonusanovember12020june302022 |